Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Investment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group (OTCPK:MTLHY) for approximately 510 billion JPY (3.3 ...
Hillenbrand sells majority stake in mechanical engineering company to Bain Capital / Net losses, weak order intake © 2001-2025 Plasteurope.com | Imprint | Privacy | Cookie settings ...
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
Despite revenue declines, Hillenbrand Inc (HI) focuses on strategic divestitures and strong aftermarket performance to drive ...
Guidance to Reflect Transaction; Maintains Outlook for Remaining Businesses BATESVILLE, Ind., Feb. 5, 2025 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: ...
Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...
Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...
Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...
According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.
Highlights,Hillenbrand's Q1 revenue of $707 million decreased 9% year-over-year, in line with expectations.,The company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results